1.Study on Pharmacokinetics of Paeoniflorin and Phillyrin from Qianliean Granules in Rats in vivo
Xi TIAN ; Zhenjiang LIANG ; Anran GUO ; Xiuling YANG
China Pharmacy 2016;27(10):1363-1366
OBJECTIVE:To establish a method for determining the plasma concentration of paeoniflorin and phillyrin and phar-macokinetic study before and after intragastric administration of Qianliean granules. METHODS:LC-MS/MS method was adopted. The column was Waters C18 with mobile phase consisted of acetonitrile(A)-2 mmol/L ammonium acetate(containing 0.05% formic acid)(B)(0-9 min:15%A→50%A;9-11 min:50%A→90%A;11-17 min:90%A;17-19 min:90%A→15%A;19-20 min:15%A),at the flow rate of 0.6 ml/min;column temperature was 35 ℃ and the volume was 20 μl;quantitative ions were paeoniflorin m/z 525.2 → m/z 449.0,phillyrin m/z 552.3 → m/z 355.3. 7 SD male rats were docked to collect blood 0.5 ml from angular vein 0.25,0.5,0.75,1,1.5,2,3,4,6,8,10,12,24 h after administration Qianliean granule solution 1 g(medicinal materials)/kg to determine the blood concentration of drugs. DAS 2.1.1 software was employed to calculate pharmacokinetic parameters. RE-SULTS:The linear range of paeoniflorin and phillyri were 5.0-2500.0 μg/L(r=0.9979)and 2.0-2000.0 μg/L(r=0.9982),re-spectively;RSD of precision test was less than 5.5%(n=5);the method recovery were 96.0%-104.0% and 92.0%-107.0%,the extration recovery were 71.4%-83.5% and 81.5%-92.3% and RSD of stability test was less than 5.0%(n=3). The pharmacokinet-ic parameters of paeoniflorin and phillyrin were as follows as t1/2 of (2.206 ± 0.631) and (1.355 ± 0.317) h;cmax of (1504.069 ± 620.885) and (79.043 ± 15.568)μg/L;tmax of (1.000 ± 0.250) and (1.214 ± 0.267) h;AUC0-24 h of (4897.645 ± 2207.577) and (263.475±54.795)μg·h/L;CL of(5.025±2.773)and(76.253±13.986)L/(h·kg). CONCLUSIONS:The method is highly sensi-tive,exclusive,simple,accurate and reliable,and can be applied to study the pharmacokinetic characteristics of paeoniflorin and phillyrin in rats in vivo.
2.Progress on the effects of respiratory tract flora on bronchopulmonary dysplasia of premature infants
International Journal of Pediatrics 2021;48(10):686-688
Bronchopulmonary dysplasia(BPD)is a common chronic lung disease in preterm infants, which seriously affects the survival rate of preterm infants.Its etiology and pathogenesis are complex and unclear.Therefore, the prevention, diagnosis and treatment of BPD have become an important clinical issue.With the rapid development of high-throughput sequencing technology, it has been found that the respiratory tract flora can act as an early biomarker of BPD risk, and then judge the progress of BPD and the timing of treatment, so as to achieve the purpose of early treatment and improved prognosis.This article mainly describes the changes in the diversity and abundance of the respiratory tract flora of BPD in premature infants, the mechanism of action of the flora on BPD, and the future treatment methods based on the flora.
3.Recent advances in behavioral and psychological symptoms of Alzheimer's disease
Chinese Journal of Neuromedicine 2023;22(2):189-193
Behavioral and psychological symptoms of dementia (BPSD) is a common symptom of Alzheimer's disease (AD), with an occurrence of 90%. BPSD can lead to poor prognosis and dysfunction in patients with AD, but few safe and effective treatments are available. This article overviews the occurrence frequencies of different manifestations of BPSD in AD and their changes with clinical courses of the disease, and introduces the current research progress on genetic characteristics, pathophysiological mechanism, biomarkers and therapeutics of BPSD in AD to provide references for early recognition and treatment of BPSD in AD.
4.The application of low temperature-storing tumor lumps in vitro in establishing VX2 liver cancer models:study of its modeling effect
Anran GUO ; Ning CHEN ; Anna LIU ; Ling LI
Journal of Interventional Radiology 2024;33(3):269-274
Objective To compare the effect of using the fresh tumor lump and the recovered low temperature-storing VX2 tumor lump that have been frozen for different time to construct the rabbit HCC model.Methods Fish-like fresh VX2 tumor lumps were selected.After the peripheral necrotic tissue and muscle were removed,the tumor lumps were frozen at-80℃ for 3,5 and 7 months.Twenty New Zealand white rabbits were randomly divided into 4 groups.The rabbits in group A(control group)received fresh liver tumor lump implantation to construct in-situ VX2 rabbit HCC models.The rabbits in groups B,C and D(experimental groups)received implantation of the recovered low temperature-storing VX2 tumor lump which had been frozen at-80℃ for 3,5 and 7 months,respectively,to construct in-situ VX2 rabbit HCC models.Fourteen days after implantation,the modeling effect of tumor formation in each group was assessed.The proliferation,apoptosis of tumor cells and the angiogenesis were evaluated by immunofluorescence assay.Results The tumor formation rate of all group A,B,C and D was 100%.However,with the extension of cryopreservation time,the difference in tumor mass activity became larger after 5 months,and the necrotic area of liver tumor center became enlarged.Histological examination showed that there were no significant differences in the expressions of TUNEL,Ki67,HIF-α,VEGF and CD31 between group A and group B,while there were significant differences in the expressions of TUNEL,Ki67,HIF1-α,VEGF and CD31 between group A,B and group C,D.Conclusion The rabbit VX2 HCC model,which is constructed by implantation of recovered low temperature-storing VX2 tumor lump being frozen at-80℃ in vitro for a certain time,can be successfully established within 7 months.The difference in tumor mass activity between tumor lumps became larger after 5 months.But on the whole,the constructed rabbit VX2 HCC model can better preserve the tumor strain activity.This modeling technique can save manpower and material resources.(J Intervent Radiol,2024,33:269-274)